QSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction

Postnatal growth failure is often attributed to dysregulated somatotropin action, however marked genetic and phenotypic heterogeneity exist. We report five patients from three families who present with short stature, immune dysfunction, atopic eczema and gastrointestinal pathology associated with recessive variants in QSOX2. QSOX2 encodes a nuclear membrane protein linked to disulphide isomerase and oxidoreductase activity. Loss of QSOX2 disrupts Growth hormone-mediated STAT5B nuclear translocation despite enhanced Growth hormone-induced STAT5B phosphorylation. Moreover, patient-derived dermal fibroblasts demonstrate Growth hormone-induced mitochondriopathy and reduced mitochondrial membrane potential. Located at the nuclear membrane, QSOX2 acts as a gatekeeper for regulating stabilisation and import of phosphorylated-STAT5B. Altogether, QSOX2 deficiency modulates human growth by impairing Growth hormone-STAT5B downstream activities and mitochondrial dynamics, which contribute to multi-system dysfunction. Furthermore, our work suggests that therapeutic recombinant insulin-like growth factor-1 may circumvent the Growth hormone-STAT5B dysregulation induced by pathological QSOX2 variants and potentially alleviate organ specific disease.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-09-28
DOI
https://doi.org/10.1038/s41467-024-52587-w
Citations
7
Primary Topic
RNA regulation and disease
Type
article
Field-Weighted Citation Impact
1.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

QSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction

Afiya Andrews, Vivian Hwa, Anni Joensuu, Miho Ishida et al.
7 citations
Nature Communications
RNA regulation and disease
1.64
article

QSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction

Afiya Andrews, Vivian Hwa, Anni Joensuu, Miho Ishida, John R. B. Perry, Frances Elmslie, Katri Kantojärvi, Anna Rybak, Helen L. Storr, Avinaash Maharaj, Raina Jia, Liam James McGuffin, Edel A. O’Toole, Aakash Joshi, Reem Elfeky
article en
7 citations

Abstract

Postnatal growth failure is often attributed to dysregulated somatotropin action, however marked genetic and phenotypic heterogeneity exist. We report five patients from three families who present with short stature, immune dysfunction, atopic eczema and gastrointestinal pathology associated with recessive variants in QSOX2. QSOX2 encodes a nuclear membrane protein linked to disulphide isomerase and oxidoreductase activity. Loss of QSOX2 disrupts Growth hormone-mediated STAT5B nuclear translocation despite enhanced Growth hormone-induced STAT5B phosphorylation. Moreover, patient-derived dermal fibroblasts demonstrate Growth hormone-induced mitochondriopathy and reduced mitochondrial membrane potential. Located at the nuclear membrane, QSOX2 acts as a gatekeeper for regulating stabilisation and import of phosphorylated-STAT5B. Altogether, QSOX2 deficiency modulates human growth by impairing Growth hormone-STAT5B downstream activities and mitochondrial dynamics, which contribute to multi-system dysfunction. Furthermore, our work suggests that therapeutic recombinant insulin-like growth factor-1 may circumvent the Growth hormone-STAT5B dysregulation induced by pathological QSOX2 variants and potentially alleviate organ specific disease.

Nature CommunicationsVol. 15(1)
Cincinnati Children's Hospital Medical Center (US), Queen Mary University of London (GB), University of Cambridge (GB), Great Ormond Street Hospital (GB), St George’s University Hospitals NHS Foundation Trust (GB), Finnish Institute for Health and Welfare (FI), MRC Epidemiology Unit (GB), University College London (GB), University of Reading (GB), The University of Osaka (JP)
Queen Mary University of London, Wellcome Trust, Barts Charity, Cancer Research UK, National Institute for Health and Care Research, Department of Health and Social Care, Medical Research Council, Biotechnology and Biological Sciences Research Council
Openalex Percentile: Top 16%
RNA regulation and disease
1.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.